Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Siponimod

EU orphan designation number: EU/3/14/1370   
Active ingredient: Siponimod
Indication: Treatment of polymyositis
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/147/14 (2014)8866 of 19/11/2014